Furthermore, and despite a relatively low number of serum EV samples, both studies were able to detect higher amounts of TGFβ in AML patients and describe the role of this growth factor in the inhibition of NK-cell activity [189]. This evidence concerns the gene TGFB1 and acute myeloid leukemia.